|
2023
|
Invention
|
Alkaline phosphatase for use in oncology. inter aliainter alia, to combination therapies of speci... |
|
2022
|
Invention
|
Alkaline phosphatase-based treatments of celiac disease. The present disclosure relates, inter al... |
|
2020
|
Invention
|
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics. This in... |
|
|
Invention
|
Intestinal alkaline phosphatase-based treatments of metabolic disorders. The present invention re... |
|
|
Invention
|
Alkaline phosphatase formulations and uses thereof. The present invention provides, in part, form... |
|
|
Invention
|
Beta-lactamase compositions for treatment of graft versus host disease.
The present invention re... |
|
|
Invention
|
Beta-lactamase compositions for treatment of graft versus host disease. The present invention rel... |
|
|
Invention
|
Alkaline phosphate-based oncology treatments. The present invention relates to methods and compos... |
|
2019
|
Invention
|
Methods of making alkaline phosphatase agents. inter aliainter alia, compositions and methods, in... |
|
|
Invention
|
Intestinal alkaline phosphatase formulations. The present invention provides for a formulation co... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of radiation disorders. inter aliainter alia, compositi... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of neurodevelopmental disorders. The present invention ... |
|
2018
|
Invention
|
Beta-lactamase formulations.
The present invention provides, in part, formulations comprising a ... |
|
|
Invention
|
Beta-lactamase formulations. The present invention provides, in part, formulations comprising a b... |
|
|
Invention
|
Alkaline phosphatase formulations. The present invention provides, in part, formulations comprisi... |
|
2017
|
Invention
|
Methods and compositions for attenuating antibiotic resistance. The present invention provides, i... |
|
|
Invention
|
Stabilized pertussis antibodies with extended half-life. The present invention relates, in part, ... |
|
|
Invention
|
Microbiome protection from oral antibiotics. This invention provides, in part, various compositio... |
|
|
Invention
|
Clinically efficacious anti-methanogenic compositions and uses. The present invention relates to,... |
|
|
Invention
|
Anti-methanogenic compositions.
The present invention relates, in part, to treatment of various ... |
|
|
Invention
|
Anti-methanogenic compositions. The present invention relates, in part, to treatment of various d... |
|
2016
|
Invention
|
Anti-methanogenic lovastatin analogs or derivatives and uses thereof. The present invention relat... |
|
|
Invention
|
Safe and effective beta-lactamase dosing for microbiome protection. The present invention relates... |
|
|
Invention
|
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome. This inv... |
|
|
Invention
|
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome.
This in... |
|
2015
|
Invention
|
Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics. This i... |
|
|
Invention
|
Methods and compositions for inhibiting clostridium difficile. The present invention relates to, ... |
|
|
Invention
|
Beta-lactamase formulations and uses thereof. The present invention provides, in part, formulatio... |
|
|
Invention
|
E. coli-based production of beta-lactamase. The invention relates to, in part, improved methods f... |
|
|
Invention
|
Anti-methanogenic compositions and uses thereof. The present invention relates to, in part, metho... |
|
|
Invention
|
Beta-lactamases with improved properties for therapy. This invention relates to, in part, composi... |
|
|
Invention
|
Humanized pertussis antibodies and uses thereof. The present invention relates to humanized antib... |
|
2010
|
Invention
|
Gastroretentive oral high dose zinc preparations. A sustained-release zinc composition preferably... |
|
2008
|
Invention
|
Oral zinc medicants useful for safely lowering free copper absorption and free copper levels.
A ... |
